infectious-diseases-endocrinology-2019-posters-abstracts

13 / 20

Page 47
conferenceseries.com
Volume 7 Journal of Infectious Diseases & Therapy Infectious Diseases & Endocrinology 2019
February 27-28, 2019
February 27-28, 2019 Tokyo, Japan
Infectious Diseases, Diabetes and Endocrinology
Global Experts Meeting on
J Infect Dis Ther 2019, Volume 7
DOI: 10.4172/2332-0877-C2-063
A report of rate and antibiotic resistance patterns of global threatening bacteria in Iran
Leila Azimi, Shahnaz Armin, Fatemeh Fllah, Abdollah Karimi and Saeid Maham
Shahid Beheshti University of Medical Sciences, Iran
Antibiotic resistance is a worldwide health problem. Antibiotic resistance can increase rate of mortality and morbidity
especially in immunosuppress patients like hospitalized one. Antibiotic-resistant infections add considerable costs to the
nation’s already overburdened health care system. Estimates regarding the medical cost per patient with an antibiotic-resistant
infection range from $ 18,588 to $ 29,069 in 2015. The total economic burden placed on the US economy by antibiotic-
resistant infections has been estimated to be as high as $ 20 billion in health care costs. It can be considerable that making and
introducing new antibiotics are very low because there is no economic justification because of early appearance of resistance.
The most critical group of all includes multidrug resistant bacteria that pose a particular threat in hospitals, nursing homes and
among patients whose care requires devices such as ventilators and blood catheters. They include Acinetobacter, Pseudomonas
and various Enterobacteriaceae (including Klebsiella, E. coli, Serratia and Proteus). They can cause severe and often deadly
infections such as bloodstream infections and pneumonia. WHO priority pathogens list for R&D of new antibiotics:
Priority 1: Critical
Acinetobacter baumannii, carbapenem-resistant
Pseudomonas aeruginosa, carbapenem-resistant
Enterobacteriaceae, carbapenem-resistant, ESBL-producing
Priority 2: High
Enterococcus faecium, vancomycin-resistant
Staphylococcus aureus, methicillin-resistant, vancomycin-intermediate and resistant
Priority 3: Medium
Streptococcus pneumoniae, penicillin-non-susceptible
So, in this report we explain about rate of present and also antibiotic resistance patterns of these global threating bacteria in
Iran as an Asian country.